2014
DOI: 10.7314/apjcp.2014.15.2.769
|View full text |Cite
|
Sign up to set email alerts
|

Fangchinoline Inhibits Cell Proliferation Via Akt/GSK-3beta/cyclin D1 Signaling and Induces Apoptosis in MDA-MB-231 Breast Cancer Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
34
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(37 citation statements)
references
References 14 publications
3
34
0
Order By: Relevance
“…Fangchinoline also induced autophagic cell death via p53/sestrin2/AMPK signaling in human hepatocellular carcinoma cells (24). Reports also indicated that fangchinoline inhibited cell proliferation via Akt/GSK-3β/cyclin D1 signaling and induce apoptosis in MDA-MB-231 breast cancer cells (10,11,25). Researchers pointed out that fangchinoline could achieve the inhibition of lung cancer and glioma role by regulating multiple signaling pathways (26,27).…”
Section: Discussionmentioning
confidence: 99%
“…Fangchinoline also induced autophagic cell death via p53/sestrin2/AMPK signaling in human hepatocellular carcinoma cells (24). Reports also indicated that fangchinoline inhibited cell proliferation via Akt/GSK-3β/cyclin D1 signaling and induce apoptosis in MDA-MB-231 breast cancer cells (10,11,25). Researchers pointed out that fangchinoline could achieve the inhibition of lung cancer and glioma role by regulating multiple signaling pathways (26,27).…”
Section: Discussionmentioning
confidence: 99%
“…antagonizes multidrug resistance-related drugs by targeting P-glycoprotein, which may improve drug resistance in chemotherapy [21]. Fcn targets the PI3K/Akt/GSK-3β pathway and induces apoptosis [13]. Fcn can also modulate cell cycle-related proteins, such as PCNA, p27 and cyclin D, and thus induces G1/S arrest in prostate cancer [20].…”
Section: Fangchinoline Induces Energetic Impairment In Bladder Cancermentioning
confidence: 99%
“…Fcn is a potent antioxidant, showing protective effects in oxidative cell injury [10]. This compound was also found to inhibit the growth of several cancers, such as lung cancer, breast cancer and prostate cancer, through proliferation inhibition and/or apoptosis [11][12][13][14] and induces autophagic cell death in hepatocellular cancer cells [15]. More recently, Fcn was found to block the well-known P-glycoprotein, indicating that Fcn may enhance the effects of chemotherapy drugs and prevents multidrug resistance [16].…”
Section: Introductionmentioning
confidence: 99%
“…Additionally, most studies have revealed the therapeutic potential of fangchinoline, an alkaloid derived from the dry roots of Stephania tetrandra S Moore (Menispermaceae). It can inhibit the proliferation of MCF-7 and MDA-MB-231 human breast cancer cells and PC3 human prostate carcinoma cells via G1-phase arrest [125, 126] and induce apoptosis in breast cancer cells via the mitochondrial apoptotic pathway and Akt/GSK-3beta/cyclin D1 signaling [127, 128]. Fangchinoline effectively suppressed the proliferation and invasion of lung cancer A549 cells by inhibiting p-FAK and its downstream pathways [129] and induced autophagic cell death via p53/sestrin2/AMPK signaling in hepatocellular carcinoma HepG2 and PLC/PRF/5 cells [130].…”
Section: Effects Of Tetrandrine Analogs and Other Bisbenzylisoquinolimentioning
confidence: 99%